Stimulation of Hair Growth by Topical Application of FK506, a Potent Immunosuppressive Agent  by Yamamoto, Satoshi et al.
Stimulation of Hair Growth by Topical Application of 
FK506, a Potent Immunosuppressive Agent 
Satoshi Yamamoto, Hong Jiang, and Ryuichi Kato 
Department of Pharmacology, School of Medicine, Keio University, Tokyo, Japan 
FKS06, a macrolide antibiotic produced by Streptomyces tsu-
kubaensis, is known as a potent T cell- specific immunosup-
pressant, and is effective against graft rejection after organ 
transplantation. Topical application of FKS06 (0.03-1 
}lmol) to dorsal skin of CO-1 mice stimulated hair growth in 
a dose-dependent manner. Unlike topical application, oral 
administration of 30 mg/kg of FKS06, a dose that induces 
marked immunosuppression, did not stimulate significant 
hair growth. Topical application of FKS06 also stimulated 
hair growth of rats and Syrian golden hamsters. FKS06 stim-
ulated hair growth even in SCIO mice that lack both B- and 
T -cell immunity. Therefore, it is unlikely that the hair 
growth - stimulatory effect of FKS06 results from its immu-
nosuppressive effect. FKS06 (0.01-1 }lM) stimulated both 
C yclosporin A (CsA), an inhibitor ofT-cell activation, is currently a favored therapeutic agent for preven-tion of graft rejection after organ transplantation [1]. Another immunosuppressant, FK506, a recently dis-covered macrolide antibiotic, is effective against graft 
rejection at much lower doses compared to CsA [2-5]. Although 
CsA and FK506 differ considerably in structure, they have quite 
similar actions [6 - 9]. The adverse effects ofFK506 and CsA are also 
very similar, including nephrotoxicity and impaired glucose toler-
ance [1,10-12] . 
It has been reported that CsA stimulates hair growth [13-19]. 
One of the most common dermatologic side effects of the drug is 
dose-dependent hypertrichosis [1,14,15]. The cause of CsA-in-
duced hypertrichosis, however, has not been elucidated yet. Con-
trary to the case of CsA, there have been no reports showing that 
FK506 induces hypertrichosis. Recently we have demonstrated that 
the topical application of FK506 markedly inhibits tumor promo-
tion caused by 12-0-tetradecanoylphorbol-13-acetate (TP A) in the 
two-stage carcinogenesis of mouse skin [9]. During this experiment, 
we observed an obvious stimulation of hair growth by topical appli-
cation but not by oral administration ofFK506. In the present study, 
we investigated this hair growth - stimulatory effect of FK506. 
MATERIALS AND METHODS 
FK506 was supplied by Fujisawa Pharmaceutical Co., Osaka, Japan. CD-l 
mice and SCID (C.B-17 scid/scid) mice were purchased from Charles River, 
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[3H]thymidine and (3H]glycine uptakes to cultured mouse 
vibrissae follicles in a concentration-dependent manner. 
Moreover, when the follicles were treated with FKS06 
(1 }lM) for 16 d, the size of the follicles (length of hair plus 
follicle) increased slightly but significantly. On the other 
hand, the size of the non-treated follicles did not increase 
significantly. These results indicate that FKS06 directly 
stimulates hair follicles. Long-term treatment of mice with 
FKS06, i.e., topical application of 1 }lmol FKS06 twice a 
week for 6 months, did not affect body weight gain of mice, 
and the FKS06-treated mice looked healthy. FKS06 may be 
useful as a stimulant of hair growth. Key words: oral adminis-
tration/SCID mouse/ (3H] thymidine uptake/ (3H]glycine uptake. 
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Atsugi,Japan and Japan Clea Co., Tokyo,Japan, respectively. Syrian golden 
hamsters were obtained from Tokyo Laboratory Animal Science, Tokyo 
Japan. The following materials were purchased from the companies indi~ 
cated: [3H)thymidine (80.3 Ci/mmol) and [3H)glycine (48.4 Ci/mmol), 
from DuPont/NEN Research Products, Boston, MA; polyethylene glycol 
400, from Nakarai Chemicals Co., Kyoto, Japan; culture media, from 
Gibco, Grand Island, NY; Soluene-350, from Packard Instrument Com-
pany, Meriden, CT; ACS II, from Amersham Corporation, Arlington 
Heights, IL; trypsin 1 : 250, from Difco Laboratories, Detroit, MI; Chelex 
100, from Bio-Rad Laboratories, Richmond, CA; and fetal calf serum, from 
Hyclone, Logan, UT. The other chemicals used were of reagent grade. 
Hair-Growth Experiments Animals were housed in an air-conditioned 
room (22-23°C) with a light period from 6 AM to 6 PM. Food and water 
were available ad libitum. In the case of SCID mice, the mice were main_ 
tained under specific-pathogen free conditions behind a barrier in rooms 
with HEPA-filtered air, and food and water were autoclaved. Every SCID 
mouse we used was checked immunologically by the breeder, i.e.,Japan Clea 
Co., Tokyo,Japan, before supplying. For the hair-growth experiments, both 
CD-1 and SCID mice, 7 - 8 weeks of age, were used. 
Dorsal hair of each animal was shaved with clippers at least 2 d before use. 
To see the effect of topical application, FK506 was dissolved in acetone and 
applied to the shaved area in a volume of 0.2 ml using a micropipet. The 
second application was performed 3 d after the first application. To see the 
effect of oral administration, FK506 was dissolved in 100% polyethylene 
glycol 400 and administered orally. The second administration was per_ 
formed 3 d after the first administration. The external appearance of animals 
was recorded by macrophotography either 16, 19, or 21 d after the first 
treatment with FK506. Each group consisted of four animals. All the experi-
ments were repeated at least three times on completely different occasions 
using animals from different litters. The mice used were randomly chosen 
from 50 - 100 animals in each experiment. 
Preparation of Vibrissae Follicles Vibrissae were harvested from 
CD-1 mice at 8 d of age. The mice were killed by cervical dislocation and the 
whisker pads were removed and washed twice with phosphate-buffered 
saline without Ca++ and Mg++ [PBS(-)) supplemented with 100 U/m1 
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Figure 1. Effect of topical application of FK506 on hair growth of CD-l 
mice. Dorsal hair of female CD-l mice was shaved with clippers 2 d before 
use. The indicated amounts of FK506 or vehicle (acetone) were topically 
applied to the shaved area. The same amounts of FK506 or vehicle were 
topically applied again 3 d after the first application. Nineteen days after the 
first application, macrophotography of the external appearance was taken. 
Similar experiments were repeated three times, and the results obtained were 
always reproducible. 
penicillin G, 100 pg/ml streptom~cin sulfate, an~ 0.25 pg/ml fungiz.one. 
Whisker pads were treated first with 0.2% trypsm-PBS(-) for 10 mm at 
37°C, then with 0.250/.0 trypsin-PBS(-) for 10 min at 37"C. Follicles were 
dissected from the whisker pads using forceps under a stereomicroscope and 
rinsed twice with the PBS(-) supplemented with antibiotics and twice with 
the low-Ca++ culture medium [20], i.e., Ca++-free Eagle's minimum essen-
tial medium supplemented with 10% chelex-treated (Ca++-deprived) fetal 
bovine serum, 50 pM CaCI2 (final concentration), 100 U/ml penicillin G, 
100 pg/ ml streptomycin sulfate, and 0.25 pg/ml fungizone. Fifteen follicles 
were plated on each 35-mm plastic culture dish and cultured in the above 
low-Ca++ culture medium in an atmosphere of9S% air/S% CO2 at 37°C. 
Viability of cells in follicles was estimated by a trypan blue exclusion test. 
pH]Thymidine and ['H]Glycine Uptake Uptakes of [3H]thymidine 
and [,H]glycine into vibrissae follicles cultured in the low-Ca++ culture 
medium were examined as described by Buhl et af [21] with minor modifica-
tions. The indicated concentrations of FK506 or vehicle (final concentra-
tion, 0.1 % dimethylsulfoxide) were added to the culture medium 18 h after 
plating the follicles in culture. [3H]Glycine (final concentration, O.S /lCi! 
mJ) or ['H]thymidine (final concentration,S JlCi/ml) was added to the 
medium 24 or 48 h after the addition of FKS06, respectively. The follicles 
were further cultured at 37°C for 24 h, then rinsed with ice-cold saline for 4 
h. The ice-cold saline was changed every 1 h. The radio-labeled follicles 
were solubilized in 1 ml of Soluene-350, neutralized with 0.1 ml of 1 N 
HCl and counted in 10 ml of ACS II. 
Growth of Cultured Vibrissae Follicles Vibrissae follicles were cul-
tured in the low-Ca++ culture medium either in the presence or absence of 
FKS06 (1 pM) for 16 d. The growth of vibrissae follicles was assessed by 
measuring the length of hair plus follicles before and after the 16 d of culture. 
Long-Term Treatment with FK506 FK506 (1 /lmol) was topically 
applied to dorsal skin of mice twice a week for 6 months and the body weight 
of each mouse was recorded. 
RESULTS 
In Vivo Experiments Effect of topical application of FK506 
(0.03, 0.1, 0.3, and 1 /.lmol) on hair growth of CD-1 mice was 
examined. As shown in Fig 1, topical application of FK506 stimu-
lated hair growth of female CD-1 mice in a dose-dependent man-
ner. Even with 0.03 /.lmol, hair growth was stimulated obviously. 
Similar dose-dependent stimulation was also observed with male 
CD-l mice (data not shown). Hair growth was uniformly stimu-
lated in the shaved area by topical application of FK506. None of 
the vehicle-treated animals showed increased hair growth during 
the experimental periods. Contrary to the topical application, oral 
administration of 30 mg/kg FK506, a dose which induces a marked 
immunosuppressive effect [22], failed to stimulate hair growth (Fig 
2). Topical application of FK506 (0.3 and 3 /.lmol) also stimulated 
hair growth of SD rats (data not shown) and Syrian golden hamsters 
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Figure 2. Effect of oral administration of FK506 on hair growth of CD-l 
mice. FK506 (30 mg/kg) or vehicle (100% polyethylene glycol 400) was 
administered orally to female CD-l mice. The same amount of FK506 or 
vehicle was administered 3 d after the first administration. As a control 
experiment, FK506 (1 /lmol) was topically applied to the other group of 
mice (see legend to Fig 1). Sixteen days after the first administration, macro-
photography of the external appearance was taken. Similar experiments 
were repeated three times, and the results obtained were always reproduc-
ible. 
(Fig 3). The results obtained were always reproducible, and 100% of 
the treated animals responded to FK506 in accordance with its 
doses. 
To examine whether the hair-growth-stimulatory effect of 
FK506 is related to its immunosuppressive effect, a hair-growth 
experiment was conducted using SCID mice, which lack both func-
tional T cells and B cells [23]. As clearly shown in Fig 4, even in 
SCrD mice FK506 stimulated hair growth in a dose-related manner. 
FK506 stimulated hair growth in 100% of the tested scrD mice in 
accordance with its doses. 
To assess the toxicity of FK506, the effect of chronic topical 
application ofFK506 (1 j.lmol), i.e. , twice a week for 6 months, on 
the body weight gain of CD-l mice was examined. FK506 did not 
affect body weight gain of mice (Fig 5) and the FK506-treated mice 
looked healthy. 
In Vitro Experiments Vibrissae follicles cultured for 48 - 72 h in 
normal Ca++ medium showed necrotic changes along the hair ma-
trix that were detected by trypan blue exclusion test. The result was 
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Figure 3. Effect of topical application of FK506 on hair growth of Syrian 
golden hamsters. Dorsal hair of Syrian golden hamsters was shaved with 
clippers 2 d before use. The indicated amounts ofFK506 or vehicle (acetone) 
were topically applied to the shaved area. The same amounts of FK506 or 
vehicle were topically applied again 3 d after the first application. Nineteen 
days after the first application, macrophotography of the external appear-
ance was taken. Similar experiments were repeated three times, and the 
results obtained were always reproducible. 
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Figure 4. Effect of topical application of FK506 on hair growth of SCID 
mice. Dorsal hair ofSCID mice was shaved with clippers 2 d before use. The 
indicated amounts of FK506 or vehicle (acetone) were topically applied to B 
the shaved area. The same amounts of FK506 or vehicle were topically 
applied again 3 d after the first application. Twenty-one days after the first 
application, macrophotography of the external appearance was taken. Simi-
lar experiments were repeated three times, and the results obtained were 
always reproducible. 
consistent with the data reported by Buhl et at [21]. Such necrotic 
changes were minimum when follicles were cultured in the low-
Ca-++ (50 J.lM) culture medium. Under the low-Ca-++ condition, 
follicles maintained normal gross morphology even after 16 d of 
culture (Fig 6) . Therefore, the low-Ca-++ culture medium was used 
for in vitro culture of vibrissae follicles. Under this culture condi-
tion, effects of FK506 on PH]thymidine and [3H]glycine uptakes 
into the follicles were examined. FK506 stimulated both (3H]thy-
midine and (3H]glycine uptakes into the follicles in a concentration- C 
dependent manner (Figs 7 and 8). 
Significant stimulation of [3H]thymidine and PH]glycine up-
takes into follicles by FK506 was also observed under normal Ca-++ 
culture condition, though the stimulation was less distinct com-
pared to that observed under the low-Ca-++ culture condition (data 
not shown). 
We next examined the effect of FK506 on the growth of cultured 
vibrissae follicles, which was assessed by measuring the length of 
hair plus follicles. When the follicles were cultured with FK506 (1 
J.lM) under the low-Ca-++ condition for 16 d, length of hair plus 
follicles increased slightly but significantly (Table I). On the other 
hand, length of the non-treated follicles did not increase signifi-
cantly. FK506 did not alter the gross morphology of the follicles 
during 16 d of culture (Fig 6). 
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Figure 5. Effect oflong-term topical application ofFK506 on body weight 
gain of CD-1 mice. FK506 (1 ,umol) or vehicle (acetone) was topically 
applied to dorsal skin of female CD-1 mice twice a week for 6 months. Each 
point represents the mean of 20 mice. 
Figure 6. Comparison of the gross morphology between a freshly dissected 
follicle (A) and follicles cultured for 16 d (B,C) in the low-Ca++ (50 ,uM) 
culture medium either in the presence (C) or absence (B) ofFK506 (1,uM). 
DISCUSSION 
It is well known that one of the side effects observed after repeated 
oral administration of cyclosporin A (CsA) is hypertrichosis 
[1,14,15] . Repeated topical application of CsA also causes hair 
growth [17]. This stimulatory effect on hair growth may have a 
beneficial effect on alopecia areata [14,16,17] and male-pattern alo-
pecia [18] . It has been reported that CsA stimulates hair growth of 
athymic nude mice by enhancing keratinization of the hair [24]. 
The precise mechanism of the hair-growth-stimulatory effect of 
CsA, however, has not been elucidated. Contrary to the case of CsA, 
there have been no reports showing that FK506 induces hypertri-
chosis. 
It has been reported that both FK506 and CsA inhibit the T-cell 
activation by preventing the appearance of the T cell-specific tran-
scription factor of the IL-2 gene [25,26], i.e., NF-AT, by blocking 
the Ca-++ - and calmodulin-dependent nuclear translocation of the 
cytoplasmic component of NF-AT [26]. Inhibition of Ca-++- and 
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Figure 7. Effect ~f ~K506 o.n [3HJthymidine u~take of mouse vibrissae 
fo llicles. Fifteen vlbnssae folhcles were cultured In the low-Ca++ culture 
medium. The indicated concentrations of FK506 or vehicle (final concen-
tration, 0.1 % dimethylsulfoxide) were added to the culture medium 18 h 
after plating the follicles in culture. [3HJthymidine (final concentration,S 
J.lCi/ml) was added to the medium 48 h after the addition of FK506. The 
follicles were further cultured for 24 h, and the radioactivity of the follicles 
was counted. Each column and vertica l bar represents the mean ± SEM (n = 
3). Similar experiments were repeated twice and the data obtained were 
reproducible. 'p < 0.05 versus 0 J.lM FK506. 
calmodulin-dependent protein phosphatase, calcineurin, by FKS06 
and CsA may result in inhibition of the nuclear translocation [27]. 
Recently we have found that the topical application of FKS06 
prevents tumor promotion in the two-stage carcinogenesis of mouse 
skin [9,28]. Topical application but not oral administration of CsA 
also prevents skin tumor promotion in the same two-stage carcino-
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Figure 8. Effect of FK506 on PH]glycine uptake of mouse vibrissae folli-
cles. Fifteen vibrissae follicles were cultured in the low-Ca++ culture me-
dium. The indicated concentrations of FK 506 or vehicle (final concentra-
tion, 0.1 % dimethylsulfoxide) were added to the culture medium 18 h after 
plating the follicles in culture. [3H]glycine (fin~l. concentration, 0.5 J.lCi/ml) 
was added to the medium 24 h after the addmon of FK506. The folhcles 
were further cultured for 24 h, and the radioactivity of the follicles was 
counted. Each column and vertical bar represents the mean ± SEM (n = 3). 
Similar experiments were repeated twice and the data obtained were repro-
ducible. 'p < 0.05 versus 0 J.lM FK506. 
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Table I. Effect of FKS06 on the Growth of 
Cultured Vibrissae Follicles' 
Length of Hair Plus Follicle (mm)b 
Treatment 
Vehicle' 
FK506 (1 J.lM) 
Before Culture 
9.6 ± 0.2 
9.8 ± 0.2 
After 16 d of Culture 
9.8 ± 0.2 
11.0±0.lJ 
• Vibrissae follicles were cultured in the low-Ca++ (50 JIM) culture medium for 16 d 
eicher in the presence or absence of 1 JiM FK506. Length of each vibrissae follicle (hair 
plus follicle) was measured before and after 16 d of culture. 
! Mean ± SEM (n = 4). 
'0.1 % dimethylsulfoxide (final concentration). 
J p < 0.05 versus before culture (9.8 ± 0.2) . 
genesis model [29], and this effect may not be related to its immu-
nosuppressive effect [30] . 
As clearly shown in our present study, topical application of 
FKS06 markedly stimulated hair growth in CD-l mice. FKS06 
stimulated hair growth even in SCID mice that lack both B- and 
T-cell immunity [23]. Thus, it seems unlikely that the hair-
growth - stimulatory effect ofFK-S06 results from its immunosup-
pressive effect. Oral administration of FKS06 (30 mg/kg), which 
causes marked immunosuppression [22] , did not induce obvious hair 
growth. The result also supports the above contention that the 
immunosuppressive effect of FKS06 is essentially unrelated to its 
hair-growth-stimulatory effect. At present it is unclear whether 
hair-growth - stimulatory effects of FKS06 and CsA are manifested 
through a common mechanism. 
The failure of oral administration of FKS06 to induce hair 
growth is compatible with the fact that FKS06 does not induce 
hypertrichosis in clinical trials. It is possible that the concentration 
ofFKS06 in skin may not reach high enough to induce the stimula-
tion of hair growth after oral administration of this compound. 
The hair-growth - stimulatory effect of FKS06 was observed 
both in male and female animals and not only in mice but also in rats 
(unpublished data) and hamsters. In vitro studies on the growth of 
vibrissae follicles and the incorporation of radio-labeled thymidine 
and glycine into hair follicles revealed that FKS06 directly stimu-
lates hair follicles . 
Because long-term treatment of mice with FKS06, i.e., topical 
application of 1 ,umol FKS06 twice a week for 6 months, did not 
deteriorate the healthy condition of mice, it may be possible that the 
systemic immunosuppressive effect of FKS06 is not manifested by 
the chronic topical application of this agent. Potential use ofFKS06 
for a therapeutic purpose as a stimulant of hair growth may be 
anticipated. Hair-growth - stimulatory effect of FKS06 in humans 
is now under investigation in our laboratory. 
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ANNOUNCEMENT 
The 43rd Annual Symposium on the Biology of Skin will be held in Snowmass, Colorado 
August 6 -1 0, 1994. The topic of this year's meeting will be "Lymphocytes in Skin Disease: 
From Activation to Immunodeficiency." 
The meeting will consist of invited oral and poster presentations. Enrollment is limited to 
150 participants. A limited number of posters will be accepted for presentation. Deadline for 
poster abstract submission is June 1, 1994. Those wishing to submit abstracts for poster presen-
tations or requesting registration materials should write to David A. Norris, M.D., The Cuta-
neous Biology Foundation, Box B-144, Department of Dermatology, University of Colorado 
School of Medicine, 4200 E. Ninth Avenue, Denver, CO 80262. 
